首页 › 期刊 › 医学 › Journal of Managed Care & Specialty Pharmacy
Journal of Managed Care & Specialty Pharmacy
出版商:Academy of Managed Care Pharmacy · ISSN:2376-0540, 2376-1032 · 国家/地区:US · 类型:journal · 创刊:1995 · 官网:http://www.jmcp.org
研究主题:Medication Adherence and Compliance · Health Systems, Economic Evaluations, Quality of Life · Pharmaceutical Practices and Patient Outcomes · Pharmaceutical Economics and Policy · Economic and Financial Impacts of Cancer
数据覆盖:8 个公开学术数据源交叉核验(crossref、fqb、jcr、openalex、scimago、wikidata、xr、cwts)。
数据来源与实体核验
期刊官网 · OpenAlex 期刊实体 · Wikidata 期刊实体
核心指标
- 影响因子(JCR 2025):3.300
- JCR 分区:Q2(HEALTH CARE SCIENCES & SERVICES)
- 中科院分区(2025):医学 4区,大类排名 2432/5603;小类:HEALTH CARE SCIENCES & SERVICES 卫生保健与服务 4区,排名 88/173
- 新锐分区(2026):医学 3区
- SJR:1.212(Q1),2025 年,United States
- CWTS 2025:SNIP 1.064 · IPP 3.128 · 自引率 8.2%
- h-index:61
- i10 指数:737
- 近两年篇均被引:2.38
- 载文量 1877 · 总被引 25074
- Crossref DOI 总量:1876,近期 423
逐年趋势
- 近年影响因子:2020 2.9 → 2021 2.34 → 2022 2.1 → 2023 2.3 → 2024 2.9
- 近年 SJR:2021 0.699(Q1) → 2022 0.76(Q1) → 2023 0.766(Q1) → 2024 1.02(Q1) → 2025 1.21(Q1)
同学科期刊推荐
- CA-A CANCER JOURNAL FOR CLINICIANS — IF 685.2 · JCR Q1 · 中科院1区(Top)
- The Lancet — IF 109.0 · JCR Q1 · 中科院1区(Top)
- MMWR Surveillance Summaries — IF 96.9 · JCR Q1 · 中科院1区(Top)
- Nature Reviews Clinical Oncology — IF 94.6 · JCR Q1 · 中科院1区(Top)
- Nature Reviews Drug Discovery — IF 91.2 · JCR Q1 · 中科院1区(Top)
- New England Journal of Medicine — IF 84.5 · JCR Q1 · 中科院1区(Top)
- Signal Transduction and Targeted Therapy — IF 81.2 · JCR Q1 · 中科院1区(Top)
- Annals of Oncology — IF 80.4 · JCR Q1 · 中科院1区(Top)
常见问题
《Journal of Managed Care & Specialty Pharmacy》的影响因子是多少?
根据 JCR 2025 年数据,《Journal of Managed Care & Specialty Pharmacy》的最新影响因子(IF)为 3.300。
《Journal of Managed Care & Specialty Pharmacy》是几区期刊?
《Journal of Managed Care & Specialty Pharmacy》中科院分区(2025年版)为医学4区,JCR 分区为 Q2。
本刊近期代表论文
- Clinical characteristics and treatment patterns of patients with NTRK fusion–positive solid tumors: A multisite cohort study at US academic cancer centers (2024 · 被引 6)
- Health care resource utilization and costs for treatment-experienced people with HIV switching or restarting antiretroviral regimens since 2018 (2024 · 被引 4)
- Validation of EHR medication fill data obtained through electronic linkage with pharmacies (2021 · 被引 44)
- Estimating HIV Management and Comorbidity Costs Among Aging HIV Patients in the United States: A Systematic Review (2020 · 被引 28)
- Major Bleeding Risk During Anticoagulation with Warfarin, Dabigatran, Apixaban, or Rivaroxaban in Patients with Nonvalvular Atrial Fibrillation (2017 · 被引 120)